Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.260
+0.050 (4.13%)
At close: Apr 28, 2026, 4:00 PM EDT
1.240
-0.020 (-1.59%)
After-hours: Apr 28, 2026, 5:28 PM EDT
Dermata Therapeutics Employees
Dermata Therapeutics had 9 employees as of December 31, 2025. The number of employees increased by 1 or 12.50% compared to the previous year.
Employees
9
Change (1Y)
1
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
-$839,840
Market Cap
5.07M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Jaguar Health | 47 |
| PMGC Holdings | 34 |
| Aptevo Therapeutics | 33 |
| Cardio Diagnostics Holdings | 17 |
| Revelation Biosciences | 9 |
| Ernexa Therapeutics | 7 |
| Alpha Compute | 4 |
| Mustang Bio | 4 |
DRMA News
- 26 days ago - Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System - Accesswire
- 4 weeks ago - Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025 - Accesswire
- 5 weeks ago - Dermata Shares Rise After USPTO Issues Patent Notice Of Allowance - Benzinga
- 7 weeks ago - Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing - Accesswire
- 7 weeks ago - Dermata Opens a New Chapter with the Release of Tome Skincare - Accesswire
- 3 months ago - Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office - Accesswire
- 4 months ago - Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Accesswire
- 4 months ago - Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Accesswire